LifeSync
Josh Stapleton has a diverse work experience spanning several companies in the healthcare industry. Josh is currently the Vice President of Operations at LifeSync since August 2022. Prior to that, they worked at ZimVie as the Senior Director of Operations from March 2022 to August 2022.
Josh's longest tenure was at Zimmer Biomet, where they held multiple roles. From September 2020 to March 2022, they served as the Senior Director of Operations. Before that, they were the Director of Operations from September 2016 to September 2020. Josh started at Zimmer Biomet as the Associate Director of Distribution Operations and Sites Leader in January 2013, where they managed commercial field operations and distribution for spinal implants/sets.
Before joining Zimmer Biomet, Josh worked at Biomet as the Global Concurrent Engineering Manager from February 2012 to January 2013. Josh was responsible for the commercialization of new products and managed a team of engineers and operators.
Josh's career began at Smith & Nephew Orthopaedics, where they held various roles. Josh was the Engineering Manager for recon knee orthopaedic implants from April 2010 to January 2012. Prior to that, they worked as a Manufacturing Engineer III from August 2007 to April 2010 and as a Manufacturing Engineer II from September 2004 to August 2007. Josh also started their career as a Research Engineer Intern, involved in testing trauma and recon products for FDA 510k filings.
Josh's earliest work experience was at Tennessee Veterinary Hospital, where they served as a Research Engineer from January 2002 to January 2004.
Josh Stapleton completed their education at the University of Tennessee, Knoxville. Josh obtained a Bachelor's degree in Biomedical Engineering in 2002 and later pursued a Master's degree in Mechanical Engineering, which they completed in 2004.
This person is not in any offices
LifeSync
1 followers
LifeSync is a rapidly expanding Florida-based designer, contract manufacturer, and seller of patient monitoring connections and accessories for cardiac and neurological diagnostic markets. LifeSync has grown significantly in recent years, in large part, through the acquisition of established medical product providers. In 2019, LifeSync purchased American Biosurgical Inc. (ABI) and Vital Connections (VC). With the addition of ABI, LifeSync now offers comprehensive, cost-effective contract manufacturing services for OEM monitoring companies. VC provides unique design and manufacturing capabilities built around highly specialized materials and processes. VC also expands LifeSync’s radiolucent lead wire portfolio—a growing category that enables efficient throughput for patients undergoing imaging procedures like MRIs. ABI and VC join three other market-leading companies acquired since 2012 by LifeSync’s owner, HealthEdge Investment Partners. These successful strategic acquisitions allow LifeSync to deliver components that fit all monitoring systems—standardization that streamlines care, increases efficiency, and reduces costs. Today, LifeSync is a top provider of disposable ECG lead wires, which support key infection prevention initiatives. LifeSync is well-positioned to meet the increasing demands for monitoring in both existing categories like cardiac care and emerging areas, such as sleep science and wireless healthcare delivery. With more than 1,300 employees and operations in the U.S., Mexico, and China, LifeSync directly serves hospitals and health systems, and provides full contract manufacturing capabilities for diagnostic/monitoring device makers worldwide.